ASX Announcement

Nasodine in vitro and pilot human COVID-19 studies published

Published: 10/02/22, 09:30am (AEST)2 pages
Firebrick Pharma Limited
FRE:ASXHealthcare

Recent FRE Announcements

Price Sensitive only